Business
Ondine Biomedical appoints new Board of Directors
Ondine Biomedical appoints new Board of Directors.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n \n \n \n RNS Number : 7501U\n Ondine Biomedical Inc.\n 07 December 2021\n \n \n \n \n 7 December 2021 Ondine Biomedical Inc.\n \n \n (\"Ondine Biomedical\" or the \"Company\")\n \n \n \n \n \n Ondine Biomedical appoints new Board of Directors\n \n \n Canadian life sciences company, Ondine Biomedical, has appointed a new Board of Directors with considerable medtech and pharma expertise following its listing on the London AIM market. Key appointments include the Honourable Jean Charest, former Deputy Prime Minister of Canada, as Chairman, and Dr. Junaid Bajwa, the Chief Medical Scientist at Microsoft Research. Carolyn Cross, Founder and CEO of Ondine, and Nicolas G. Loebel, PhD, President and Chief Technology Officer, will remain on the Board. \n Ondine is at the forefront of development of photodisinfection-based therapies to address the large and growing need for solutions to a broad spectrum infections, including drug-resistant strains. Its lead product, Steriwave™, is a photodisinfection-based medical device to decolonize the nose of harmful pathogens that can lead to healthcare-associated infections (HAIs). Steriwave has been deployed in Canadian hospitals for over ten years and has contributed to significant reductions in infection rates.\n \n The Honourable Jean Charest - Chairman\n The new Chairman of the Board, the Honourable Jean Charest, is the former Deputy Prime Minister of Canada and the former Premier of the Province of Quebec. With a public service career spanning almost 30 years, Mr. Charest is one of Canada's best-known political figures; he was first elected to the House of Commons in 1984 and, at age 28, became Canada's youngest cabinet minister. Mr. Charest is a Partner with McCarthy Thetrault and remains active in public policy and community activities.\n \n \n \n Jean Duvall - Non-executive Director and Senior Independent Director\n Jean Duvall joins Ondine as non-executive Director and Senior Independent Director. Ms. Duvall is Co-Founder and was Chair of cell and gene therapy specialist, Trizell Holding, and initiated and drove Ferring's entry into gene and cell therapy by leading the acquisition of assets and founding of Tri...